Aktis Oncology (AKTS) Stock
Aktis Oncology (AKTS) closed at $16.16 on Nov 16, 2026; its Tenet Score is 52 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $16.16
- Nov 16, 2026
- Market cap
- $899.3M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 13.96 – 34.19
- low → high, since listing
- Tenet Score
- 52/100
- Mixed · 409 Healthcare peers
Industry: Pharmaceutical Preparations · see every company filed here →
Aktis Oncology Inc scores 52/100. Mixed. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 52 is built from 2 of 4 pillars, from 20% of its inputs. The pillars showing a dash had no data, and Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
- ✕ Quality Floor
Pays no dividend. Every dollar of profit is reinvested into the business.
We are a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The field of targeted radiopharmaceutica…
Similar-sized companies in Pharmaceutical Preparations
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Kailera Therapeutics Inc.KLRA | 56 | $1.7B |
| Generate Biomedicines IncGENB | 28 | $1.6B |
| Rapport Therapeutics Inc.RAPP | 56 | $1.6B |
| LB Pharmaceuticals IncLBRX | 64 | $1.4B |
| Avalyn Pharma Inc.AVLN | 50 | $1.3B |
| Alto Neuroscience Inc.ANRO | 53 | $1.2B |
| Seaport Therapeutics Inc.SPTX | 58 | $1.1B |
| Alumis Inc.ALMS | 55 | $727.0M |
| Bicara Therapeutics Inc.BCAX | 59 | $685.1M |
| ArriVent BioPharma Inc.AVBP | 55 | $644.3M |
Common questions
What sector and industry is Aktis Oncology in?
Aktis Oncology is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Aktis Oncology's Tenet Score?
Aktis Oncology's Tenet Score is 52 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




